Search Results - "Fregeville, A."

Preoperative imaging and prediction of oesophageal conduit necrosis after oesophagectomy for cancer by Lainas, P., Fuks, D., Gaujoux, S., Machroub, Z., Fregeville, A., Perniceni, T., Mal, F., Dousset, B., Gayet, B.

“…Background Oesophageal conduit necrosis following oesophagectomy is a rare but life‐threatening complication. The present study aimed to assess the impact of…”
Get full text

Renal Tumor Biopsy: Rationale to Avoid Surgery in Small Renal Masses by Amaral, B.S., Macek, P., Arora, A., Pazeto, C.L., Zugail, A.S., Mombet, A., Fregeville, A., Lefevre, M., Sanchez-Salas, R., Cathelineau, X.

“…Purpose of Review The use of renal tumor biopsy (RTB) for small renal masses (SRMs) in daily practice, although safe and accurate, is unusual. Considering the…”
Get full text

Renal tumor biopsy: Rationale to avoid surgery in small renal masses by Amaral, B., Macek, P., Sanchez-Salas, R., Linck Pazeto, C., Zugail, A.S., Arora, A., Fregeville, A., Marinho, F., Lefevre, M., Cathala, N., Mombet, A., Cathelineau, X.

Get full text

High intensity focused ultrasound with Focal-One ® device: Prostate-specific antigen impact and morbidity evaluation during the initial experience by Perez-Reggeti, J I, Sanchez-Salas, R, Sivaraman, A, Linares Espinos, E, de Gracia-Nieto, A E, Barret, E, Galiano, M, Rozet, F, Fregeville, A, Renard-Penna, R, Cathala, N, Mombet, A, Prapotnich, D, Cathelineau, X

“…We report our initial experience in the treatment of prostate cancer (PCa) with high-intensity focused ultrasound (HIFU) using the Focal-One device…”
Get more information

High intensity focused ultrasound with Focal-One® device: Prostate-specific antigen impact and morbidity evaluation during the initial experience by Perez-Reggeti, J.I, Sanchez-Salas, R, Sivaraman, A, Linares Espinos, E, de Gracia-Nieto, A.E, Barret, E, Galiano, M, Rozet, F, Fregeville, A, Renard-Penna, R, Cathala, N, Mombet, A, Prapotnich, D, Cathelineau, X

“…Abstract Objective We report our initial experience in the treatment of prostate cancer (PCa) with high-intensity focused ultrasound (HIFU) using the…”
Get full text

Value of whole-body CTA in the management of brain-dead patients [in French] by Fregeville, A, de Bazelaire, C, Zagdanski, A.M, Albiter, M, Desgrandchamps, F, de Kerviler, E

“…Purpose To assess the value of whole body computed tomographic angiography (CTA), as a complement to head CTA, in the management of brain-dead patients as…”
Get full text

5-year outcomes of High-Intensity Focused Ultrasound (HIFU) treatment of localised prostate cancer by Deleuze, C., Barret, E., Fregeville, A., Rozet, F., Macek, P., Barbe, Y., Lainé, C., Mandoorah, Q., Mombet, A., Cathala-Mignon, N., Cathelineau, X.

Get full text

Reply by Authors by Claros, O. R, Tourinho-Barbosa, R. R, Fregeville, A., Gallardo, A. C., Muttin, F., Carneiro, A., Stabile, A., Moschini, M., Macek, P., Cathala, N., Mombet, A., Sanchez-Salas, R., Cathelineau, X.

Get full text

V11 USG and MP-MRI fused images for guiding HIFU in the focal treatment of prostate cancer by De Gracia-Nieto, A.E, Sánchez-Salas, R, Barret, E, Sivaraman, A, Fregeville, A, Renard-Penna, R, Rozet, F, Galiano, M, Cathelineau, X

Get full text

Reply by Authors by Claros, O R, Tourinho-Barbosa, R R, Fregeville, A, Gallardo, A C, Muttin, F, Carneiro, A, Stabile, A, Moschini, M, Macek, P, Cathala, N, Mombet, A, Sanchez-Salas, R, Cathelineau, X

Get full text

Value of whole body CTA in the management of brain-dead patients by Fregeville, A, De Bazelaire, C, Zagdanski, Am, Albiter, M, Desgrandchamps, F, De Kerviler, E

“…To assess the value of whole body CTA, as a complement to head CTA, in the management of brain-dead patients as potential organ donors. Materials and Methods…”
Get full text

Which non-ischemic myocardial diseases show delayed enhancement, and what are their imaging characteristics by Silvera, S, Palangié, E, Marmursztejn, J, Daoud, B, Fregeville, A, Gouya, H, Legmann, P, Vignaux, O

Get full text

Aspergillose médiastinale à Aspergillus flavus chez une patiente immunocompétente by Angoulvant, A., Wyplosz, B., Validire, P., Fregeville, A., Caliandro, R., Gossot, D., Stern, J.-B.

Get full text

Intérêt de l’angioscanner corps entier dans la prise en charge du patient en état de mort encéphalique by Fregeville, A., de Bazelaire, C., Zagdanski, A.M., Albiter, M., Desgrandchamps, F., de Kerviler, E.

“…To assess the value of whole body CTA, as a complement to head CTA, in the management of brain-dead patients as potential organ donors. A total of…”
Get full text

Spinal cord injury without radiographic abnormality: review of the literature by Fregeville, A, Dumas de la Roque, A, De Laveaucoupet, J, Mordefroid, M, Gajdos, V, Musset, D

Get full text

Traumatisme médullaire sans anomalie radiologique visible (SCIWORA) : à propos d’un cas et revue de la littérature by Fregeville, A., Dumas de la Roque, A., De Laveaucoupet, J., Mordefroid, M., Gajdos, V., Musset, D.

Get full text

Quelles pathologies myocardiques non ischémiques ont un rehaussement tardif et avec quelles caractéristiques ? by Silvera, S., Palangié, E., Marmursztejn, J., Daoud, B., Fregeville, A., Gouya, H., Legmann, P., Vignaux, O.

Get full text

Quelles pathologies myocardiques non ischémiques ont un rehaussement tardif et avec quelles caractéristiques ?: Imagerie cardiaque by SILVERA, S, PALANGIE, E, MARMURSZTEJN, J, DAOUD, B, FREGEVILLE, A, GOUYA, H, LEGMANN, P, VIGNAUX, O

Get full text

Coroscanner : peut-on s’affranchir des beta-bloquants ? experience sur un an avec un scanner bi-tube by Daoud, B., Gouya, H., Fregeville, A., Palangié, E., Silvera, S., Legmann, P., Vignaux, O.

“…Evaluation de la qualité des coroscanners réalisés consécutivement sur une année avec un scanner bi-tube, sans l’utilisation de béta-bloquants. Trois cent…”
Get full text

Quelles pathologies myocardiques chroniques non ischemiques ont un rehaussement tardif en IRM avec quelles caracteristiques by Silvera, S., Palangié, E., Marmursztejn, J., Daoud, B., Fregeville, A., Gouya, H., Legmann, P., Vignaux, O.

“…Connaître le principe de la séquence de rehaussement tardif (RT) en IRM. Connaître les trois principaux critères sémiologiques permettant d’identifier les…”
Get full text